Krasemann S et al. reported that the TREM2-APOE pathway serves as the primary regulator of phenotypic alterations in microglia during neurodegenerative diseases, making it a potential target for reinstating microglial homeostasis [49]. This evidence concerns the gene TREM2 and neurodegenerative disease.